Researchers from project BERENICE lead the first world clinical trial of a new drug against Chagas disease. The study reveals that posaconazole, a drug that had obtained great results in animal models, it is less effective than the current treatment.


The research has represented the starting signal for further clinical trials in Chagas disease. Researchers from BERENICE project are now studying new ways of current drug administration using Nanomedicine under BERENICE project.


This study leaded by Dr. Israel Molina was recently published in the prestigious medical journal New England Journal of Medicine.

Download Article